Matches in Wikidata for { <http://www.wikidata.org/entity/Q64172230> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q64172230 description "clinical trial" @default.
- Q64172230 description "ensayu clínicu" @default.
- Q64172230 description "klinik çalışma" @default.
- Q64172230 description "klinisch onderzoek" @default.
- Q64172230 description "клінічне випробування" @default.
- Q64172230 name "Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas" @default.
- Q64172230 type Item @default.
- Q64172230 label "Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas" @default.
- Q64172230 prefLabel "Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas" @default.
- Q64172230 P1050 Q64172230-1834ABB3-D890-4773-80F8-05DE9F39C992 @default.
- Q64172230 P1132 Q64172230-55E5A47C-1D5F-4A54-BD6E-D9BFDB39379D @default.
- Q64172230 P1476 Q64172230-41DEE804-CC0F-4C5D-A1CA-3566A4148609 @default.
- Q64172230 P17 Q64172230-E6DF4C3B-87A6-4FD6-AEDB-3068D2EBC66B @default.
- Q64172230 P2899 Q64172230-A387331C-354F-4CD1-811C-36BE581F5DA6 @default.
- Q64172230 P3098 Q64172230-55368503-922B-4CD9-B236-C2B564628202 @default.
- Q64172230 P31 Q64172230-247A67E6-CBEC-482E-8597-CF4E340BEA7C @default.
- Q64172230 P4844 Q64172230-A9AB71AD-61A1-4264-AFFA-DE1EC93A47EE @default.
- Q64172230 P4844 Q64172230-AE3208F9-E198-4505-A5CD-7811C20B6DEC @default.
- Q64172230 P4844 Q64172230-CE3B6512-8BCA-4093-9FA5-9DCE1A94C223 @default.
- Q64172230 P580 Q64172230-3388569F-C216-4FD6-B741-F4720C15054D @default.
- Q64172230 P582 Q64172230-0ACE36B3-8D87-40DC-A156-EDDB82330E82 @default.
- Q64172230 P6099 Q64172230-7A54366B-A57B-4AEA-ABBF-8ED890FD8D76 @default.
- Q64172230 P8363 Q64172230-DF496D11-1BED-4887-8929-4E0454094821 @default.
- Q64172230 P921 Q64172230-C7E107C3-71F7-4E61-8A6E-4753E21C3AE3 @default.
- Q64172230 P1050 Q208414 @default.
- Q64172230 P1132 "+25" @default.
- Q64172230 P1476 "Phase 2 Trial of Lenalidomide (Revlimid)-Dexamethasone + Rituximab in Recurrent Small B-Cell Non-Hodgkin Lymphomas (NHL) Resistant to Rituximab" @default.
- Q64172230 P17 Q30 @default.
- Q64172230 P2899 "+18" @default.
- Q64172230 P3098 "NCT00783367" @default.
- Q64172230 P31 Q30612 @default.
- Q64172230 P4844 Q408524 @default.
- Q64172230 P4844 Q412323 @default.
- Q64172230 P4844 Q425681 @default.
- Q64172230 P580 "2008-07-01T00:00:00Z" @default.
- Q64172230 P582 "2013-12-01T00:00:00Z" @default.
- Q64172230 P6099 Q42824440 @default.
- Q64172230 P8363 Q78089383 @default.
- Q64172230 P921 Q123251 @default.